A detailed history of Lecap Asset Management LTD transactions in Repligen Corp stock. As of the latest transaction made, Lecap Asset Management LTD holds 11,264 shares of RGEN stock, worth $1.64 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
11,264
Previous 13,031 13.56%
Holding current value
$1.64 Million
Previous $1.64 Billion 2.05%
% of portfolio
0.36%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$119.79 - $167.35 $211,668 - $295,707
-1,767 Reduced 13.56%
11,264 $1.68 Billion
Q2 2024

Jul 23, 2024

BUY
$120.0 - $182.95 $1.56 Million - $2.38 Million
13,031 New
13,031 $1.64 Billion
Q4 2023

Jan 29, 2024

BUY
$114.17 - $185.35 $152,987 - $248,369
1,340 New
1,340 $241 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.09B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Lecap Asset Management LTD Portfolio

Follow Lecap Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lecap Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lecap Asset Management LTD with notifications on news.